Table 2.
Effect of In-Hospital APAP on Cardiac Function 3 Days Postrandomization
| Variables | Control | Treatment | Difference Between APAP Effects/p Value |
|---|---|---|---|
| LVEF, % | 4.6/0.03 | ||
| Final, 3 d postrandomization | 25.8 | 30.4 | |
| Baseline | 25.4 | 26.3 | |
| Change from baseline (final to baseline) | − 0.2 | 4.4 | |
| LVESV, mL | −24.8/0.0007 | ||
| Final, 3 d postrandomization | 169 | 144 | |
| Baseline | 169 | 171 | |
| Change from baseline (final to baseline) | 3.2 | − 22.1 | |
| LVEDV, mL | −23.9/0.03 | ||
| Final, 3 d postrandomization | 228 | 204 | |
| Baseline | 227 | 235 | |
| Change from baseline (final to baseline) | 2.1 | -22 |